Model-based survival estimates of female breast cancer data

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 6, 2014, Pages 2893-2900

  Khan, Hafiz Mohammad Rafiqullah ^a   Saxena, Anshul ^a   Gabbidon, Kemesha ^a   Rana, Sagar ^a   Ahmed, Nasar Uddin ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Bayesian method; Model development; Predictive inference

Indexed keywords

ADULT; AGED; BAYES THEOREM; BREAST TUMOR; CANCER REGISTRY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MIDDLE AGED; MONTE CARLO METHOD; MORTALITY; PROBABILITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BAYES THEOREM; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MARKOV CHAINS; MIDDLE AGED; MODELS, STATISTICAL; MONTE CARLO METHOD; PROGNOSIS; SEER PROGRAM; SURVIVAL RATE;

EID: 84899804622     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.6.2893     Document Type: Article

References (63)

1. American Cancer Society (ACS) (2012). Breast Cancer Facts & Figures 2011-2012. Atlanta: American Cancer Society.
2. ACS (2013). Cancer Facts and Figures. Atlanta: American Cancer Society.
3. Ahmed SE, Tomkins RJ (1995). Estimating lognormal mean using uncertain prior information, Pakistan J Statistics, 11, 67-92.
4. Ahmed SE, Budsaba K, Lisawadi S, Volodin AI (2008). Parametric estimation for the Birnbaum-Saunders lifetime distribution based on a new parameterization, Thailand Statistician, 6, 213-40.
5. Ahsanullah M, Ahmed SE (2001). Bayes and empirical Bayes estimates of survival and hazard functions of a class of distributions. Lecture Notes in Statistics, 148, 81-7.
6. Akaike H (1973). Information theory and an extension of the maximum likelihood principle. N.Petrov and E. Caski (eds), Budhapest: Addademiai Kiado, Proceedings of the 2nd International Symposium on Information Theory.
7. Baghestani AR, Hajizadeh E, Fatemi SR (2009). Bayesian analysis for survival of patients with gastric cancer in Iran. Asian Pac J Cancer Prev, 10, 823-6.
8. Barton MK (2013). Potential survival benefit with lumpectomy for patients with early stage breast cancer. CA Cancer J Clin, 63, 217-8.
9. Burstein HJ, Prestrud AA, Seidenfeld J, et al (2010). American Society of Clinical Oncology clinical practice guidelines: Update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol, 28, 3784-96
10. Congdon P (2007). Mixtures of spatial and unstructured effects for spatially discontinuous health outcomes. Computational Statistics and Data Analysis, 51, 3197-212.
11. Feigelson HS, James TA, Single RM, et al (2013). Factors associated with the frequency of initial total mastectomy: results of a multi-institutional study. J Am Coll Surg, 216, 966-75.
12. Ferlay J, Soerjomataram I, Ervik M, et al (2013). GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer.
13. Gampenrieder SP, Rinnerthaler G, Greil R. (2013). Neoadjuvant chemotherapy and targeted therapy in breast cancer: past, present, and future. J Oncol, 2013, 732047.
14. Gilks WR, Richardson S, Spiegelhalter DJ (1996). Markov Chain Monte Carlo in Practice. Chapman & Hall, Suffolk.
15. Giuliano AE, Hunt KK, Ballman KV, et al (2011). Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA, 305, 569-75.
16. Goel S, Gupta N, Walcott BP, et al (2013). Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression. J Natl Cancer Inst, 105, 1188-201.
17. Goldhirsch A, Winer EP, Coates AS, et al (2013). Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol, 24, 2206-23.
18. Graham LJ, Shupe MP, Schneble EJ, et al (2014). Current approaches and challenges in monitoring treatment responses in breast cancer. J Cancer, 5, 58-68.
19. Gupta RD, Kundu D (1999). Generalized exponential distributions. Aust N Z J Stat, 41, 173-88.
20. Gupta RD, Kundu D (2001). Exponentiated exponential family: An alternative to gamma and Weibull distributions. Biometrical J, 43, 117-30.
21. Hou N, Huo D (2013). A trend analysis of breast cancer incidence rates in the United States from 2000 to 2009 shows a recent increase. Breast Cancer Res Treat, 138, 633-41.
22. Jafari-Koshki T, Schmid VJ, Mahaki B (2014). Trends of breast cancer incidence in Iran During 2004-2008: A Bayesian space-time model. Asian Pac J Cancer Prev, 15, 1557-61.
23. Jemal A, Bray F, Center M, et al (2011). Global Cancer Statistics. CA Cancer J Clin, 61, 69-90.
24. Khatcheressian JL, Hurley P, Bantug E, et al (2013). Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. JCO, 31, 961-65.
25. Khan HMR (2012a). Estimating predictive inference for responses from the generalized rayleigh model based on complete sample, J Thai Statistician, 10, 53-68.
26. Khan HMR (2012b). Several priors based inference from the exponential model under censoring, JP J Fund Appl Stat, 2, 1-13.
27. Khan HMR (2012c). Predictive inference for a future response using symmetrically trimmed sample from the half-normal model, Comput Stat Data Anal, 56, 1350-61.
28. Khan HMR (2012d). Improved predictive inference for responses based on location parameter median from the Rayleigh model given a doubly censored sample, Communications in Statistics - Theory and Methods, 41, 4427-38.
29. Khan HMR (2013a). Comparing relative efficiency from a right skewed model, JP J Biostat, 9, 1-26.
30. Khan HMR (2013b). Inferential estimates from the one-parameter half-normal model. J Thai Stat, 11, 77-95.
31. Khan HMR, Albatineh AN, Kheradia TN (2013). Local predictive estimates towards MLEs from the generalized half-normal model. J Stat Adv Theo Appl, 9, 73-98.
32. Khan HMR, Albatineh AN, Tesfa S, et al (2011a). Predictive inference from two-parameter Weibull model given a doubly censored sample of hepatocellular carcinoma of liver patients, J App Stat Sci, 19, 115-28
33. Khan HMR, Albatineh A, Alshahrani S, et al (2011b). Sensitivity analysis of predictive modeling for responses from the three-parameter Weibull model with a follow-up doubly censored sample of cancer patients, Comput Stat Data Anal, 55, 3093-103.
34. Khan HMR, Haq MS, Provost SB (2004). Predictive distributions for responses from the Weibull life testing model. J Stat Theory App, 3, 53-73.
35. Khan HMR, Provost SB, Singh A (2010). Predictive inference from a two parameter Rayleigh life model given a doubly censored sample, Commun Stat Theory Methods, 39, 1237-46.
36. Khan HM, Saxena A, Rana S, Ahmed NU (2014). Bayesian method for modeling male breast cancer survival data.. Asian Pac J Cancer Prev, 15, 663-9.
37. Kleinbaum DG, Klein M. (2012). Survival Analysis: A Self- Learning Text (3rd ed.). New York: Springer.
38. Kwan ML, Kushi LH, Weltzien E, et al (2010). Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. JCO, 28, 4410-16.
39. Litière S, Werutsky G, Fentiman IS, et al (2012). Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol, 13, 412-19.
40. Liu SZ, Zhang F, Quan PL, et al (2012). Time trends of esophageal cancer mortality in Linzhou city during the period 1988-2010 and a Bayesian approach projection for 2020. Asian Pac J Cancer Prev, 13, 4501-4.
41. Mariotto AB, Yabroff KR, Shao Y, et al (2011). Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst, 103, 117-28.
42. Montero AJ, Eapen S, Gorin B, Adler P (2012). The economic burden of metastatic breast cancer: a US managed care perspective. Breast Cancer Res Treat, 134, 815-22.
43. MRC Biostatistics Unit (2013). WinBUGS software version 1.4.3: The BUGS Project.
44. Nassar MM, Eissa FH (2003). On the exponentiated Weibull distribution. Commun Stat Theory Methods, 32, 1317-36.
45. National Cancer Institute (NCI) (2013). Breast Cancer Treatment (PDQ®). Health Professional version, updated: November 19, 2013.
46. Peairs KS, Barone BB, Snyder CF, et al (2011). Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. JCO, 29, 40-6.
47. Protani M, Coory M, Martin JH (2010). Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat, 123, 627-35.
48. Rao R, Euhus D, Mayo HG, Balch C (2013). Axillary node interventions in breast cancer: a systematic review. JAMA, 310, 1385-94.
49. Robertson C, Arcot Ragupathy SK, Boachie C, et al (2011). The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation. Health Technol Assess, 15, 1-322.
50. Sakamoto Y, Ishiguro M, Kitagawa G (1986). Akaike Information Criterion Statistics. Tokyo: D. Reidel.
51. SEER (2013). Surveillance, Epidemiology and End Results. Cancer of the Breast - SEER Stat Fact Sheets.
52. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29.
53. Smith RA, Brooks D, Cokkinides V, et al (2013). Cancer screening in the United States, 2013. CA Cancer J Clin, 63, 87-105.
54. Spiegelhalter DJ, Best NG, Carlin BP, Van der Linde A (2002). Bayesian measures of model complexity and fit (with discussion). J R Stat Soc Ser B Stat Methodol, 64, 191-232.
55. Sprague BL, Trentham Dietz A, Gangnon RE, et al (2011). Socioeconomic status and survival after an invasive breast cancer diagnosis. Cancer, 117, 1542-51.
56. U.S. Cancer Statistics Working Group (USCS). (2013). United States Cancer Statistics: 1999-2010 Incidence and Mortality Web-based Report. Atlanta: U.S. DHHS, CDC and NCI.
57. Weiner LM, Surana R, Wang S (2010). Monoclonal antibodies: versatile platforms for cancer immunotherapy. Nat Rev Immunol, 10 317-27.
58. White A, Richardson LC, Krontiras H, Pisu M (2013). Socioeconomic disparities in breast cancer treatment among older women. J Women's Health.
59. Wolfram Research (2012). The Mathematica Archive: Mathematica 8.0, Wolfram Research Inc, Illinois.
60. World Health Organization (WHO) (2013a). Cause-specific mortality and morbidity: Age-standardized mortality rate by cause by World Bank income group, 2008. Geneva: WHO.
61. WHO (2013b). Charts for the 10 leading causes of death for women worldwide and by income group, 2011. Geneva: WHO.
62. Yang XR, Chang-Claude J, Goode EL, et al (2011). Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the breast cancer association consortium studies. J Natl Cancer Inst, 103, 250-63.
63. Zurrida S, Bassi F, Arnone P, et al (2011). The changing face of mastectomy (from mutilation to aid to breast reconstruction). Int J Surg Oncol, 2011, 980158.